Alzheimer Market, Global Outlook and Forecast 2022-2028

March 2022 | 60 pages | ID: A3A9B36DF2CEEN
Market Monitor Global

US$ 3,250.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Alzheimer’s is a neurodegenerative progressive disease. Alzheimer's disease is a type of dementia whichludes a broad group of brain diseasessuch as problems with memorythinkingand behavior for the long term. It is a type of dementia and near about 60-70% of Alzheimer's disease is the cause of dementia. Many researchers consider anrease in the level of protein amyloid in the brain is one of the causes of Alzheimer disease. Older age is the prominent cause of Alzheimer'swhereas there are also some genetic and some other causes of Alzheimer diseases. The exact cause of Alzheimer’s disease is still unknown.

This report contains market size and forecasts of Alzheimer in Global, including the following market information:

Global Alzheimer Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Alzheimer market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Cholinesterase inhibitors Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Alzheimer include Allergan, Eisai, Novartis, Daiichi Sankyo, Merz Pharma, Pfizer, Johnson & Johnson and Lundbeck, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Alzheimer companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Alzheimer Market, by Drug Type, 2017-2022, 2023-2028 ($ millions)

Global Alzheimer Market Segment Percentages, by Drug Type, 2021 (%)
  • Cholinesterase inhibitors
  • Pipeline Drugs
  • NMDA receptor antagonist
Global Alzheimer Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Alzheimer Market Segment Percentages, by Application, 2021 (%)
  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Sales
Global Alzheimer Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Alzheimer Market Segment Percentages, By Region and Country, 2021 (%)
  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Russia
    • Nordic Countries
    • Benelux
    • Rest of Europe
  • Asia
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Rest of Asia
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Middle East & Africa
    • Turkey
    • Israel
    • Saudi Arabia
    • UAE
    • Rest of Middle East & Africa
Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Alzheimer revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Alzheimer revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:
  • Allergan
  • Eisai
  • Novartis
  • Daiichi Sankyo
  • Merz Pharma
  • Pfizer
  • Johnson & Johnson
  • Lundbeck
1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Alzheimer Market Definition
1.2 Market Segments
  1.2.1 Market by Drug Type
  1.2.2 Market by Application
1.3 Global Alzheimer Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL ALZHEIMER OVERALL MARKET SIZE

2.1 Global Alzheimer Market Size: 2021 VS 2028
2.2 Global Alzheimer Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Alzheimer Players in Global Market
3.2 Top Global Alzheimer Companies Ranked by Revenue
3.3 Global Alzheimer Revenue by Companies
3.4 Top 3 and Top 5 Alzheimer Companies in Global Market, by Revenue in 2021
3.5 Global Companies Alzheimer Product Type
3.6 Tier 1, Tier 2 and Tier 3 Alzheimer Players in Global Market
  3.6.1 List of Global Tier 1 Alzheimer Companies
  3.6.2 List of Global Tier 2 and Tier 3 Alzheimer Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Drug Type - Global Alzheimer Market Size Markets, 2021 & 2028
  4.1.2 Cholinesterase inhibitors
  4.1.3 Pipeline Drugs
  4.1.4 NMDA receptor antagonist
4.2 By Drug Type - Global Alzheimer Revenue & Forecasts
  4.2.1 By Drug Type - Global Alzheimer Revenue, 2017-2022
  4.2.2 By Drug Type - Global Alzheimer Revenue, 2023-2028
  4.2.3 By Drug Type - Global Alzheimer Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Alzheimer Market Size, 2021 & 2028
  5.1.2 Hospital Pharmacy
  5.1.3 Retail Pharmacy
  5.1.4 Online Sales
5.2 By Application - Global Alzheimer Revenue & Forecasts
  5.2.1 By Application - Global Alzheimer Revenue, 2017-2022
  5.2.2 By Application - Global Alzheimer Revenue, 2023-2028
  5.2.3 By Application - Global Alzheimer Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Alzheimer Market Size, 2021 & 2028
6.2 By Region - Global Alzheimer Revenue & Forecasts
  6.2.1 By Region - Global Alzheimer Revenue, 2017-2022
  6.2.2 By Region - Global Alzheimer Revenue, 2023-2028
  6.2.3 By Region - Global Alzheimer Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Alzheimer Revenue, 2017-2028
  6.3.2 US Alzheimer Market Size, 2017-2028
  6.3.3 Canada Alzheimer Market Size, 2017-2028
  6.3.4 Mexico Alzheimer Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Alzheimer Revenue, 2017-2028
  6.4.2 Germany Alzheimer Market Size, 2017-2028
  6.4.3 France Alzheimer Market Size, 2017-2028
  6.4.4 U.K. Alzheimer Market Size, 2017-2028
  6.4.5 Italy Alzheimer Market Size, 2017-2028
  6.4.6 Russia Alzheimer Market Size, 2017-2028
  6.4.7 Nordic Countries Alzheimer Market Size, 2017-2028
  6.4.8 Benelux Alzheimer Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Alzheimer Revenue, 2017-2028
  6.5.2 China Alzheimer Market Size, 2017-2028
  6.5.3 Japan Alzheimer Market Size, 2017-2028
  6.5.4 South Korea Alzheimer Market Size, 2017-2028
  6.5.5 Southeast Asia Alzheimer Market Size, 2017-2028
  6.5.6 India Alzheimer Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Alzheimer Revenue, 2017-2028
  6.6.2 Brazil Alzheimer Market Size, 2017-2028
  6.6.3 Argentina Alzheimer Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Alzheimer Revenue, 2017-2028
  6.7.2 Turkey Alzheimer Market Size, 2017-2028
  6.7.3 Israel Alzheimer Market Size, 2017-2028
  6.7.4 Saudi Arabia Alzheimer Market Size, 2017-2028
  6.7.5 UAE Alzheimer Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Allergan
  7.1.1 Allergan Corporate Summary
  7.1.2 Allergan Business Overview
  7.1.3 Allergan Alzheimer Major Product Offerings
  7.1.4 Allergan Alzheimer Revenue in Global Market (2017-2022)
  7.1.5 Allergan Key News
7.2 Eisai
  7.2.1 Eisai Corporate Summary
  7.2.2 Eisai Business Overview
  7.2.3 Eisai Alzheimer Major Product Offerings
  7.2.4 Eisai Alzheimer Revenue in Global Market (2017-2022)
  7.2.5 Eisai Key News
7.3 Novartis
  7.3.1 Novartis Corporate Summary
  7.3.2 Novartis Business Overview
  7.3.3 Novartis Alzheimer Major Product Offerings
  7.3.4 Novartis Alzheimer Revenue in Global Market (2017-2022)
  7.3.5 Novartis Key News
7.4 Daiichi Sankyo
  7.4.1 Daiichi Sankyo Corporate Summary
  7.4.2 Daiichi Sankyo Business Overview
  7.4.3 Daiichi Sankyo Alzheimer Major Product Offerings
  7.4.4 Daiichi Sankyo Alzheimer Revenue in Global Market (2017-2022)
  7.4.5 Daiichi Sankyo Key News
7.5 Merz Pharma
  7.5.1 Merz Pharma Corporate Summary
  7.5.2 Merz Pharma Business Overview
  7.5.3 Merz Pharma Alzheimer Major Product Offerings
  7.5.4 Merz Pharma Alzheimer Revenue in Global Market (2017-2022)
  7.5.5 Merz Pharma Key News
7.6 Pfizer
  7.6.1 Pfizer Corporate Summary
  7.6.2 Pfizer Business Overview
  7.6.3 Pfizer Alzheimer Major Product Offerings
  7.6.4 Pfizer Alzheimer Revenue in Global Market (2017-2022)
  7.6.5 Pfizer Key News
7.7 Johnson & Johnson
  7.7.1 Johnson & Johnson Corporate Summary
  7.7.2 Johnson & Johnson Business Overview
  7.7.3 Johnson & Johnson Alzheimer Major Product Offerings
  7.7.4 Johnson & Johnson Alzheimer Revenue in Global Market (2017-2022)
  7.7.5 Johnson & Johnson Key News
7.8 Lundbeck
  7.8.1 Lundbeck Corporate Summary
  7.8.2 Lundbeck Business Overview
  7.8.3 Lundbeck Alzheimer Major Product Offerings
  7.8.4 Lundbeck Alzheimer Revenue in Global Market (2017-2022)
  7.8.5 Lundbeck Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

LIST OF TABLES

Table 1. Alzheimer Market Opportunities & Trends in Global Market
Table 2. Alzheimer Market Drivers in Global Market
Table 3. Alzheimer Market Restraints in Global Market
Table 4. Key Players of Alzheimer in Global Market
Table 5. Top Alzheimer Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Alzheimer Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Alzheimer Revenue Share by Companies, 2017-2022
Table 8. Global Companies Alzheimer Product Type
Table 9. List of Global Tier 1 Alzheimer Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Alzheimer Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Drug Type – Global Alzheimer Revenue, (US$, Mn), 2021 & 2028
Table 12. By Drug Type - Alzheimer Revenue in Global (US$, Mn), 2017-2022
Table 13. By Drug Type - Alzheimer Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Alzheimer Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Alzheimer Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Alzheimer Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Alzheimer Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Alzheimer Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Alzheimer Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Alzheimer Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Alzheimer Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Alzheimer Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Alzheimer Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Alzheimer Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Alzheimer Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Alzheimer Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Alzheimer Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Alzheimer Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Alzheimer Revenue, (US$, Mn), 2023-2028
Table 30. Allergan Corporate Summary
Table 31. Allergan Alzheimer Product Offerings
Table 32. Allergan Alzheimer Revenue (US$, Mn), (2017-2022)
Table 33. Eisai Corporate Summary
Table 34. Eisai Alzheimer Product Offerings
Table 35. Eisai Alzheimer Revenue (US$, Mn), (2017-2022)
Table 36. Novartis Corporate Summary
Table 37. Novartis Alzheimer Product Offerings
Table 38. Novartis Alzheimer Revenue (US$, Mn), (2017-2022)
Table 39. Daiichi Sankyo Corporate Summary
Table 40. Daiichi Sankyo Alzheimer Product Offerings
Table 41. Daiichi Sankyo Alzheimer Revenue (US$, Mn), (2017-2022)
Table 42. Merz Pharma Corporate Summary
Table 43. Merz Pharma Alzheimer Product Offerings
Table 44. Merz Pharma Alzheimer Revenue (US$, Mn), (2017-2022)
Table 45. Pfizer Corporate Summary
Table 46. Pfizer Alzheimer Product Offerings
Table 47. Pfizer Alzheimer Revenue (US$, Mn), (2017-2022)
Table 48. Johnson & Johnson Corporate Summary
Table 49. Johnson & Johnson Alzheimer Product Offerings
Table 50. Johnson & Johnson Alzheimer Revenue (US$, Mn), (2017-2022)
Table 51. Lundbeck Corporate Summary
Table 52. Lundbeck Alzheimer Product Offerings
Table 53. Lundbeck Alzheimer Revenue (US$, Mn), (2017-2022)

LIST OF FIGURES

Figure 1. Alzheimer Segment by Drug Type in 2021
Figure 2. Alzheimer Segment by Application in 2021
Figure 3. Global Alzheimer Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Alzheimer Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Alzheimer Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Alzheimer Revenue in 2021
Figure 8. By Drug Type - Global Alzheimer Revenue Market Share, 2017-2028
Figure 9. By Application - Global Alzheimer Revenue Market Share, 2017-2028
Figure 10. By Region - Global Alzheimer Revenue Market Share, 2017-2028
Figure 11. By Country - North America Alzheimer Revenue Market Share, 2017-2028
Figure 12. US Alzheimer Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Alzheimer Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Alzheimer Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Alzheimer Revenue Market Share, 2017-2028
Figure 16. Germany Alzheimer Revenue, (US$, Mn), 2017-2028
Figure 17. France Alzheimer Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Alzheimer Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Alzheimer Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Alzheimer Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Alzheimer Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Alzheimer Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Alzheimer Revenue Market Share, 2017-2028
Figure 24. China Alzheimer Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Alzheimer Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Alzheimer Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Alzheimer Revenue, (US$, Mn), 2017-2028
Figure 28. India Alzheimer Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Alzheimer Revenue Market Share, 2017-2028
Figure 30. Brazil Alzheimer Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Alzheimer Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Alzheimer Revenue Market Share, 2017-2028
Figure 33. Turkey Alzheimer Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Alzheimer Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Alzheimer Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Alzheimer Revenue, (US$, Mn), 2017-2028
Figure 37. Allergan Alzheimer Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Eisai Alzheimer Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Novartis Alzheimer Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Daiichi Sankyo Alzheimer Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Merz Pharma Alzheimer Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Pfizer Alzheimer Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Johnson & Johnson Alzheimer Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Lundbeck Alzheimer Revenue Year Over Year Growth (US$, Mn) & (2017-2022)



More Publications